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Ventilatory support of the newborn
The goal of treatment is safe and
effective assistance to oxygen
delivery and carbon dioxide
removal from the tissues. Inspired
oxygen should be administered in a
controlled manner to provide
adequate but not excessive blood
oxygen tension levels. Mechanical
ventilation may be required to treat
metabolic abnormalities. There is
the need for continuous monitoring
and re- evaluation. This article is
intended to present an overview of
the embryology of the respiratory
system, pulmonary physiology in
the newborn, the principles of
oxygen therapy and mechanical
ventilation. It also discusses the
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are a frequent cause of admission
in the newborn. Respiratory
diseases have unique physiologic,
a n a t o m i c a n d c l i n i c a l
characteristics during this period
necessitating special management.
K n o w l e d g e o f t h e
pathophysiology of pulmonary
diseases and their differential
impact on the lungs of differing
stages of maturity is essential to the
safe and efficacious applications of
special techniques of treatment.
P r i n c i p l e s o f r e s p i r a t o r y
m a n a g e m e n t i n c l u d e
establishment of the airway,
ensuring oxygenation, assisted
ventilation, assessing adequacy of
ven t i l a t i on , co r r ec t ion of
metabolic abnormalities and
alleviation of cause of distress.
Introduction
Embryology of the Respiratory System
The respiratory system is an outgrowth of the ventral
wall of the foregut. While the epithelium of the
larynx, tracheal, bronchi, and the alveoli originate in
the endoderm, the cartilaginous, muscular, and
connective tissue component are mesodermal in
origin. By the 4 week of gestation, the
tracheoesophageal septum separates the tracheal
from the foregut, with the foregut gut dividing as the
lung bud anteriorly and the esophagus posteriorly.
Contact between the two is maintain through the
larynx, which is formed by the tissues of the 4 and
6 pharyngeal arches.The lung bud develop into 2
main bronchi, while the right forms 3 secondary





The development of the lung is divided into 5
overlapping stages.
Embryonic stage (3-7week) branching of the
primitive bud to form terminal
bronchioles.
Pseudo glandular stage (5-17weeks) further
division of the terminal bronchiole into 2 or
more respiratory bronchioles.
Canalicular stage (16-26week) terminal sacs
are form and the capillaries establishes close
network. The type II alveoli cells are well
delineated.
Saccular stage (26-36week) thinning of the
interstitium and fusion of type I cells, and the
capillary basement in preparation for the lung
function as an organ of gas exchange.
Alveolar stage (36week -3-8yrs of age)
secondary septal formation, further sprouting of














of the air inside the lung alveoli. When no air is
flowing into or out of the lungs, the pressures in all
parts of the respiratory tree, all the way to the alveoli,
are equal to atmospheric pressure, that is, 0 cmH O
pressure. Transpulmonary pressure is the difference
between the alveolar pressure and the pleural
pressure. It is the pressure difference between that in
the alveoli and that on the outer surfaces of the lungs,
and it is a measure of the elastic forces in the lungs that
tend to collapse the lungs at each instant of respiration,
called the .
Compliance describes the elasticity or distensibility
(e.g., of the lungs, chest wall, respiratory system) and
is calculated from the change in volume per unit
change in pressure as follows:
Compliance =
Pressure
The higher the compliance, the larger the delivered
volume per unit changes in pressure. Normally, the
chest wall is compliant in newborns and does not
impose a substantial elastic load compared to the
lungs. The range of total respiratory system
compliance (lungs + chest wall) in newborns with
healthy lungs is 0.003-0.006 L/cm H O, while
compliance in babies with RDS may be as low as
0.0005-0.001 L/cm H O. The alveolar surface tension
is an important factor affecting the compliance of the
lungs is the surface tension of the film of fluid that
lines the alveoli. If the surface tension is not kept low
when the alveoli become smaller during expiration,
they collapse in accordance with the law of Laplace.
The law states that in spherical structures like the
alveoli, the distending pressure equals 2 times the
tension divided by the radius (P = 2T/r). The low
surface tension when the alveoli are small is due to the
presence in the fluid lining the alveoli of surfactant, a
lipid surface-tension-lowering agent. Surfactant is a
mixture of dipalmitoylphosphatidyl-choline (DPPC),
other lipids, and proteins. Surfactant also helps to
prevent pulmonary edema.
Resistance describes the inherent capacity of the air
conducting system (e.g, airways, endotracheal tube
[ETT]) and tissues to oppose airflow and is expressed




Airway resistance depends on the radii of the
airways (total cross-sectional area), the length of
airways, the flow rate, and the density and viscosity
of gas. Resistance is governed by
stated as:
÷ - viscosity, l












R = 8 lη πr where R - resistance, η
4
(
Towards the end of the 6 month, type II alveoli
cells produce surfactant a phospholipids rich fluid
capable of lowering surface tension at the alveoli
surface.
Abnormalities in stage I lung aplasia,
tracheoesophageal fistula and pulmonary cysts.
Abnormalities in stage II - pulmonary
s e q u e s t r a t i o n , c y s t i c a d e n o m a t o i d
malformations, congenital diaphragmatic
hernia.
Abnormalities in stage III - Respiratory distress
syndrome (RDS) and lung hypoplasia.
Before birth, the lungs are filled with fluid that
has a high chloride content, little protein, some
mucus from bronchi gland. Fetal breathing
movement begins before birth and these
movements are important for stimulating the
development and conditioning of respiratory
muscles.
The goals of respiration are to provide oxygen to the
tissues and to remove carbon dioxide. To achieve
these goals, respiration occurs through four major
functions:
Pulmonary ventilation which involves the inflow
and outflow of air between the atmosphere and
the lung alveoli;
Diffusion of oxygen and carbon dioxide between
the alveoli and the blood gas exchange.
Transport of oxygen and carbon dioxide in the
blood and body fluids to and from the body's
tissue cells.
Regulation of ventilation and other facets of
respiration.
The lungs can be expanded and contracted in two
ways: Either by downward and upward movement
of the diaphragm to lengthen or shorten the chest
cavity or via elevation and depression of the ribs to
increase and decrease the anteroposterior diameter
of the chest cavity. Normal quiet breathing is
accomplished almost entirely by the first method
while the second method occurs during heavy
breathing and involves the use of muscles of
inspiration and expiration.
Pleural pressure is the pressure of the fluid in the thin
space between the lung pleura and the chest wall
pleura. This is normally a slight negative pressure.
On the other hand, alveolar pressure is the pressure
th
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Tidal volume (V ) is the amount of air moved in
and out of the lungs during each breath. At rest, it
is usually 67 mL/kg body weight.
Inspiratory capacity (IC) is the amount of air
inspired by maximum inspiratory effort after tidal
expiration.
Expiratory reserve volume (ERV) is the amount of
air exhaled by maximum expiratory effort after
tidal expiration.
Residual volume (RV) is the volume of gas
remaining in the lungs after maximum expiration.
Vital capacity (VC) is defined as the amount of air
moved in and out of the lungs with maximum
inspiration and expiration.
Total lung capacity (TLC) is the volume of gas
occupying the lungs after maximum inhalation.
Functional residual capacity (FRC) is the amount
of air left in the lungs after tidal expiration.
The VC, IC, and ERV are decreased in lung pathology
but are also effort dependent. The FRC represents the
environment available for pulmonary capillary blood
for gas exchange at all times. A decrease in FRC is
often encountered in alveolar interstitial diseases and
thoracic deformities. The major pathophysiologic
consequence of decreased FRC is hypoxemia.
Reduced FRC results in a sharp decline in P O during
exhalation because a limited volume is available for
gas exchange.
Gaseous exchange in the respiratory system occurs
only in the terminal portions of the airways. The gas
that occupies the rest of the respiratory system that is
not available for gas exchange with pulmonary
capillary blood dead space. This space can be divided
as the anatomic dead space (respiratory system
volume exclusive of alveoli) and the physiologic
(total) dead space (volume of gas not equilibrating
with blood, i.e, wasted ventilation). In healthy
individuals, the two dead spaces are identical; but in
disease states, there may be no exchange between the
gas in some of the alveoli and the blood, and some of
the alveoli may be overventilated.
Ventilation perfusion (V/Q) mismatch usually is
caused by poor ventilation of alveoli relative to their
perfusion. A V/Q mismatch is a major cause of
hypoxemia in infants with respiratory distress
syndrome (RDS) and other causes of respiratory
failure.
The minute volume is a product of V and respiratory
rate. Alveolar ventilation is the volume of





Thus, airway resistance is inversely proportional to
its radius raised to the 4 power. If the airway lumen
is decreased in half, the resistance will increase 16-
fold. Newborns and young infants with their
inherently smaller airways are especially prone to
marked increase in airway resistance from inflamed
tissues and secretions. In diseases in which airway
resistance is increased, flow often becomes
turbulent. Distal airways normally contribute less to
airway resistance because of their larger cross-
sectional area, unless bronchospasm, mucosal
edema, and interstitial edema decrease their lumen.
Small endotracheal tubes that may contribute
significantly to airway resistance also are important,
especially when high flow rates that lead to turbulent
flow are used. The range for total airway plus tissue
respiratory resistance values for healthy newborns is
20-40 cm H O/L/s; in intubated newborns this range
is 50-150 cm H O/L/s.
Time constant measured in seconds, is a product of
compliance and resistance.
It is a measure of how quickly the lungs can inflate or
deflate, and also a measure of how quickly the
alveoli get into equilibrium with the air passages.
Thus, the time constant of the respiratory system is
proportional to the compliance and the resistance.
For example, the lungs of a healthy newborn with a
compliance of 0.004 L/cm H O and a resistance of 30
cm H O/L/s have a time constant of 0.12 seconds.
When a longer time is allowed for equilibration, a
higher percentage of airway pressure equilibrates
throughout the lungs. The longer the duration of the
inspiratory (or expiratory) time allowed for
equilibration, the higher the percentage of
equilibration.
One time constant = 63% equilibrium.
2 time constant = 86% equilibrium.
3 time constant = 95% equilibrium.
5 time constant = 100% equilibrium.
Lungs with decreased compliance (such as in RDS)
have a shorter time constant. Lungs with a shorter
time constant will complete inflation and deflation
faster than normal lungs. Patients with shorter time
constants are best ventilated with relatively smaller
tidal volumes and faster rates to minimize peak
inflation pressure. In patients with increased airway
resistance, a fast respiratory rate (and, therefore, less
time) does not allow enough pressure equilibration








Time constant = Resistance X Compliance
For practical purposes:
37
the affinity of hemoglobin for O . The greater affinity
of fetal hemoglobin (hemoglobin F) than adult
hemoglobin (hemoglobin A) for O facilitates the
movement of O from the mother to the fetus.
O Hb dissociation curve
The control and maintenance of normal breathing
largely reside within the respiratory control centers
of the bulbopontine region of the brainstem.
Neurons within this area of the brain efferent output
to the respiratory control muscles. Multiple afferent
inputs induce modulation of the central respiratory
center efferent outputs to the respiratory and airway
muscles and lungs.
Among these inputs are signals from central and
peripheral chemoreceptors, pulmonary stretch
receptors, and cortical and reticuloactivating system
neurons. Theophylline and caffeine have been shown
to increase the central chemoreceptor ventilatory
response to CO and decrease the number of apneic
spells in premature babies.
Rapid and shallow
respirations are characteristic of parenchymal
pathology, in which the elastic work of breathing is
increased disproportionately to the resistive work of
breathing.
Subcostal, intercostal, and suprasternal
are most striking, with increased negative
intrathoracic pressure during inspiration. This occurs
in extrathoracic airway obstruction as well as diseases
of decreased compliance.
.
Expiratory wheezing is characteristic of intrathoracic








Physiologic Response to Respiratory Diseases
Inspiratory stridor is a hallmark of extrathoracic
airway obstruction
Tachypnea (RR > 60/min):
Retractions:
(V - dead space) × respiratory rate
Gas exchange occurs by the process of diffusion and
equilibration of alveolar gas with pulmonary
capillary blood.
Diffusion depends on the alveolar capillary barrier
and amount of available time for equilibration. In
health, the equilibration of alveolar gas and
pulmonary capillary blood is complete for both
oxygen and carbon dioxide. In diseases in which
alveolar capillary barrier is abnormally increased
(alveolar interstitial diseases) and/or when the time
available for equilibration is decreased (increased
blood flow velocity), diffusion is incomplete.
Because of its greater solubility in liquid medium,
carbon dioxide is 20 times more diffusible than
oxygen. Significant elevation of CO does not occur
as a result of a diffusion defect unless there is
coexistent hypoventilation.
Oxygen (O ) diffuses through the respiratory
membrane from the alveoli to the blood from where
it is transported to the tissues for utilization. O is
transported in the blood combined with the O -
carrying protein- hemoglobin. O delivery to a
particular tissue depends on the amount of O
entering the lungs, the adequacy of pulmonary gas
exchange, the blood flow to the tissue, and the
capacity of the blood to carry O The reaction is
rapid, requiring less than 0.01 s. The deoxygenation
(reduction) of Hb O is also very rapid. The
transition from one state to another (i.e deoxyHb →
OxyHb → deoxyHb) has been calculated to occur
about 10 times in the life of a red blood cell.
The oxygen-hemoglobin dissociation curve, the
curve relating percentage saturation of the O -
carrying power of hemoglobin to the PO has a
characteristic sigmoid shape. Combination of the
first heme in the Hb molecule with O increases the
affinity of the second heme for O , and oxygenation
of the second increases the affinity of the third, etc,
so that the affinity of hemoglobin for the fourth O
molecule is many times that for the first.
Three important conditions affect the oxygen-
hemoglobin dissociation curve: the pH, the
temperature, and the concentration of 2, 3-
diphosphoglycerate (DPG; 2, 3-DPG). A rise in
temperature or a fall in pH shifts the curve to the
right. When the curve is shifted in this direction, a
higher PO is required for hemoglobin to bind a
given amount of O . A convenient index of such
shifts is the P  , the PO at which hemoglobin is half






















is needed to prevent CO build up.
Non-rebreather face mask: Delivers highest FiO
at 70-100%
This works based on the Venturi
principle. It is the best method for delivering a
specific and consistent FiO . The mask can deliver
FiO of 24-55% at flow rate of 4-10L. The masks
are usually colour coded at 24%, 28%, 31%, 35%,
40% and 50%
Oxygen hood/ tent: has the added advantage of easy
visualization.
Clinical indices used include:




Central mixed venous PO
End tidal CO
These include
retinopathy of prematurity, bronchopulmonary
dysplasia, absorption atelectasis, respiratory
acidosis, ventilatory depression, suppression of
erythropoeisis. Others are the complications related
to the delivery device.
The application of end-expiratory pressure is
intended to prevent alveoli and/or terminal airways
from collapsing to airlessness. Continuous positive
airway pressure (CPAP) may be applied during
spontaneous breathing or as positive end-expiratory
pressure (PEEP) during mechanical ventilation. This
usually requires pressures between 4 to 6 cm H O for
CPAP and 3 to 8 cm H O for PEEP. The physiologic
effects of CPAP/PEEP may vary depending on the
underlying pulmonary pathology, although the
primary goal is to prevent alveolar collapse.
In the surfactant-deficient state, alveoli will collapse
at end-expiration unless a minimum distending
pressure is maintained. CPAP of 3 to 4 cm H O will
prevent alveolar collapse but will not recruit
atelectatic alveoli. Opening pressures of 12 to 15 cm
H O are required to inflate collapsed alveoli. The
infant will need to create a large distending airway
pressure in the absence of CPAP. The shear forces
from opening and closing of small airways may
contribute to alveolar epithelial damage. CPAP
theoretically could stimulate surfactant secretion.
Also, maintenance of alveolar volume will reduce
right-to-left shunting of blood through atelectatic






















Complications of Oxygen Therapy:
Monitoring Oxygen Therapy
Continuous Positive Airway Pressure
Grunting is produced by expiration against a
partially closed glottis and is an attempt to maintain
positive airway pressure during expiration for as
long as possible. Such prolongation of positive
pressure is most beneficial in alveolar diseases that
produce widespread loss of FRC, such as in
pulmonary edema, RDS and pneumonia.
The aim of respiratory support in the neonate is to
maintain adequate gas exchange, minimize risk of
lung injury, minimize haemodynamic impairment,
avoid injury to other organs, and to reduce work of
breathing.
Oxygen as a drug provided in the neonate can be
used to improve arterial oxygenation, cause
pulmonary vasodilation, and to enhance systemic
oxygen delivery.
Oxygen therapy works by increasing the fractional
inspired concentration of oxygen (FiO ) and the
oxygen flow rate. The FiO determined by the
concentration of supplemental oxygen, the flow rate
of oxygen, oxygen delivery device, and the patient
respiratory effort.
The concentration of oxygen varies depending on
the source as follows: Room air 21%, oxygen tank
100%, and oxygen concentrator >90% (varies with
the oxygen concentrator indicator).
Oxygen delivery device that can be used include
nasal cannula, nasal catheter, face mask, oxygen
hood, oxygen tent, endotracheal/nasotracheal
tube/tracheostomy
This is a low flow device that can
deliver distending pressure. It is the least expensive
and the FiO delivered is 24-40%.
It is inserted into the oropharynx,
and delivers a FiO2 similar to nasal cannula
It could easily be clogged by secretions.
There are various type which include
the simple, partial rebreathing, non-rebreathing and
the Venturi face mask.
Simple face mask: Allows unregulated flow of
room air, and the FiO delivered is 35-50%.
However an increase flow rate is needed to
prevent rebreathing.
Partial rebreather mask: Is a simple mask with an
attached reservoir. Oxygen flow rate of 6-10L
required to deliver 40-70% FiO and a high flow
Respiratory Support in the Neonate














Pressure Support Ventilation (PSV):
Flow Sensitive Ventilation (FSV):
Benefits of VG
Is a ventilatory mode in which
the mechanically delivered breaths are synchronized
to the onset of spontaneous patient breaths, but at a
lower rate. The patient may breathe spontaneously
between mechanical breaths from the continuous
flow in the ventilatory circuit.
It is a mode of
ventilation that has no set rate and only supports the
patient's own spontaneous effort. It is primarily a
weaning mode. The patient controls RR, Ti and peak
insp. Flow, while the ventilator controls only PIP.
This system synchronizes inspiration by sensing
patient effort, and also synchronizes expiration by
terminating inspiration in response to a decline in
airway flow. This results in complete synchronization
of the functioning of the baby and the ventilator
throughout the entire respiratory cycle.
Inspiration is
triggered by changes in flow and ends not according
to time but according to airway flow changes. During
inspiration, the ventilator records the peak expiratory
flow rate and subsequently terminates inspiration
when the inspiratory flow decreases to 5-10% of peak
flow. This enables both inspiratory and expiratory
synchrony. Benefits of FSV include total breath
synchronization, decreased work of breathing, less
sedation, more efficient tidal volume delivery,
improved gas exchange, and fewer complications.
Volume guaranteed (VG)
Volume associated pressure support (VAPS)
Pressure regulated volume control (PRVC)
Proportional assist ventilation (PAV)
This is a pressure-limited, time or flowcycled,
volume-targeted form of ventilation. The
microprocessor compares exhaled tidal volume of the
previous breath to the desired target and adjusts the
working pressure up or down to try to achieve the
target tidal volume. There is limit of pressure
increment from one breath to the next to a maximum
of 3cm H O to avoid overcorrection. Thus, several
breaths may be needed to reach the target tidal
volume after a sudden change. The VG mode cannot
increase pressure higher than set pressure limit.
Maintenance of constant tidal volumes in the
face of changing compliance, resistance and
changing ET- tube leak
Prevention of overdistention and volutrauma














Its initial use was directed at RDS.
However, can be used to reduce the need for
ventilatory care in extreme preterms, and is used for
the INSURE technique. It is also useful in recurrent
apnoea of prematurity, and when weaning off
conventional ventilation.
It effectively maintains Functional
Residual capacity, helps reduce infant work of
breathing, reduces the need for intubation and
mechanical ventilation, and reduces the incidence of
chronic lung disease. It results in improved non-
pulmonary outcomes (increase mean weight gain,
mean length and head circumference at 36weeks
post menstrual age).
This includes overinflation leading
to increased work of breathing, air leak syndromes,
carbon dioxide retention, decreased cardiac output
with high values, complications from delivery
device, and gastric distension.
This is an invasive life support procedure. The goal
is to optimise both gas exchange and clinical status at




mandatory ventilation (IMV) and intermittent
positive pressure ventilation (IPPV).
Provides
fixed rate of mechanical ventilation and allows
spontaneous breathing between mechanical breathes
from continuous flow of oxygen.
Consists of flow trigger and
pressure trigger
Types are the assist/control
mode, synchronized intermittent mandatory
ventilation, pressure support ventilation, flow
sensitive ventilation, and volume timed ventilation.
This modality involves
either the delivery of a synchronized mechanical
breath each time a spontaneous patient breath is
detected (ASSIST), or in the event that the patient
fails to exhibit spontaneous resp. effort , the






1. Ventilatory strategy in RDS Ensure an inspiratory
flow rate 7-12 L/min, peak inspiratory pressure
20-25cmH O and positive end expiratory
pressure 4-5cmH O. The inspiratory time should
be 0.5s while the expiratory time is set at 1.0s.
Trigger volume mode preferred. Alternative
strategy is with high frequency ventilation.
2. Ventilatory strategy in MAS
There is a high risk of pneumothorax because of
ball valve effect, thus a low PEEP should be
utilized to splint the airways. If airway resistance
is high, a slow rate, moderate pressure strategy
should be utilized. If pneumonitis is more
prominent, more rapid rates can be utilized. HFV
can be used with failed conventional ventilation
or air leaks.
3. Ventilatory strategy in air leaks
Goal is to reduce the mean airway pressure (MAP)
to as low as possible and rely on FiO to improve
oxygenation. HFOV is the modality of choice.
Maintain MAP, do not use sigh maneuver. Use
low PEEP
4. Ventilatory strategy in apnoea with normal lungs
Ensure low gas flow, low PIP 10-18cmH O, low
PEEP 3-4cmH O, and normal rates 30-
40breaths/min




An index greater than 15 indicates severe respiratory
compromise, while an index greater than 40 on
multiple occasions indicate mortality > 80%
This includes ventilation induced lung injury,
ventilation induced pneumonia, air leak syndromes,
traumatic injury to large airways and endotracheal
tube complications.
There are four mechanisms of VILI: Barotrauma
(high airway pressure), volutrauma (large tidal
volume), atelectotrauma (alveolar collapse and re-
expansion), and biotrauma (increased inflammation).
Volutrauma caused by mechanical overdistension
leads to alveolar epithelial cell damage, alveolar
protein damage, altered lymphatic flow, hyaline
membrane formation, and inflammatory cell influx in
the lungs. The precise tidal volume required to
minimize volutrauma is not known. Therefore efforts
to limit tidal volume may be a beneficial practice in








Complications of Mechanical Ventilation
Ventilator Induced Lung Injury (VILI)
· Automatic lowering of pressure support level
during weaning (auto-weaning). As the
patient's lungs improve and compliance
increases, peak inspiratory pressure is weaned
automatically.
Virtually any infant requiring
mechanical ventilation especially when lung
mechanics are likely to change, or in patients with
heterogenous lung disease because of differing time
constant throughout lung parenchyma
HFV is a form of mechanical ventilation that uses
small tidal volumes, sometimes less than anatomic
dead space, and extremely rapid ventilator rates.
HFV delivers at high frequency: 300-1200/min=5-
20 HzU and utilizes very small tidal volumes and can
detect incomplete inspiration and expiration. Causes
dampening of the oscillations along the airways and
ensures a nearly constant alveolar pressure. Also,
HFV has the ability to independently manage
ventilation and oxygenation, while ensuring the safe
use of mean airway pressure that is higher than that
generally used during conventional mechanical
ventilation.
HFFI (Higher-Frequency Flow interrupting
Ventilation)
HFJV (High- Frequency Jet Ventilation)
HFOV (High-Frequency Oscillatory Ventilation)
Indications for HFOV: Rescue therapy and air leak
syndromes.
start
at 4-6cm H O and increase gradually to a maximum
of 7-8cm H O. It is titrated by: clinical assessment of
retractions, respiratory rates, and oxygen saturation.
Strategies need to be developed for the various
disease states requiring ventilation in the neonate.
Setting parameters are required for the inspiratory
flow rate, peak inspiratory pressure, positive end
expiratory pressure, oxygen concentration,
inspiratory time, expiratory time, trigger volume.
Derived parameters are the FiO2, mean airway
pressure, flow parameters, tidal volume, and the
respiratory rate.
Indications for VG:
CPAP: Mildly affected neonates with RDS:
High Frequency Ventilation
HFV in comparison to conventional IMV
Types of HFV
Clinical Applications of Mechanical Ventilation




Retinopathy of prematurity is a vaso-proliferative
retinal disorder that decreases with gestational age.
Approximately 65% of infants with a birth weight
less than 1250g and 80% of those with a birth weight
less than 1000g will develop some degree of
retinopathy of prematurity.
This can be defined as a mechanical means of
providing oxygen delivery and carbon dioxide
removal for patients who have cardiac and/or
respiratory failure. May be veno-arterial or veno-
venous.
Indication
Critically ill term and late preterm newborns with
reversible respiratory and/or cardiac failure who
have failed appropriate maximal medical
management.
In conditions such as meconium aspiration
syndrome, respiratory distress syndrome,
persistent pulmonary hypertension of the
newborn, pneumonia, sepsis, severe rhythm
disturbances, neonatal cardi0myopathies
Specific indications
Respiratory criteria: OI >30-40 for 4 hours, acute
deterioration with intractable hypoxaemia,
barotrauma with severe air leak not responsive to
HFOV
Cardiovascular/oxygen delivery criteria:Cardiac
arrest, plasma lactate >45mg/dl with metabolic
acidosis not improving or escalating with despite
adequate medical care, mixed venous saturation
<55% for 1 hour
Contraindications
These include: Gestational age less than 32 weeks
and/ or birth weight less than1800g, mechanical
ventilation beyond 10-14 days due to likely
irreversible lung disease, intraventricular
hemorrhage greater than grade I, and coagulopathy
unlikely to resolve with transfusion. Others are
severe congenital anomalies, uncorrectable cardiac
lesions, CDH with OI>45, hypoxic ischaemic
encephalopathy, and plasma lactate >225mg/dl.
Complications
These are acute renal failure, hypertension,
haemolysis, seizures, hypotension, CNS infarction,
intracranial haemorrhages, sepsis, surgical bleeding,
pulmonary haemorrhage, disseminated intravascular
coagulopathy (DIC), and brain death. Others are
cannula problems, air embolism, pump failure, and
clot formation.
This involves the use of surfactant







Ventilator Associated Pneumonia (VAP)
Air-leak syndromes
Tracheal injury and endotracheal tube related
complications
This is defined as pneumonia in mechanically
ventilated patients that develops ≥ 48 h after the
patient has been placed on mechanical ventilation.
VAP is the second most common hospital acquired
infection among neonatal intensive care unit (NICU)
patients. This is often caused by organisms such as
Pseudomonas aeruginosa (the most common),
Staphylococcus aureus, Enterobacter species, and
Klebsiella pneumoniae
Diagnostic criteria for VAP
Worsening gas exchange (oxygen desaturation or
increased oxygen or ventilatory requirements)
and 3 of the following:
Temperature instability with no obvious cause.
Leukopenia or leukocytosis with left shift.
Increased pulmonary secretions or greater need
for suctioning.
Examination reveals apnea, tachypnea, nasal flaring
with chest retractions, grunting. Wheezing, rales,
rhonchi may be present, with either bradycardia or
tachycardia.
Strategies to reduce VAP will include to prevent
contamination of equipment, ensure endotracheal
tube care, and to minimize duration of intubation.
T h e s e i n c l u d e : P n e u m o t h o r a x ,
pneumomediastinum, pneumopericardium,
pulmonary inters t i t ia l emphysema, and
subcutaneous emphysema.
Risk factors for air-leak syndromes in neonates are
extreme low birth weight, endotracheal tube
displacement, using long inspiratory time (> 0.5
sec), ↑ PIP, ↑ Vt. Also, increase in clinical
interventions including suction procedures, chest
radiography, reintubation, bag & mask ventilation
and chest compressions are risk factors. Other risk
factors are MAS, RDS, pulmonary hypoplasia.
These include subglottic stenosis, tracheal
perforation, palatal deformities, vocal cord avulsion,
laryngeal oedema, subglottic cysts, necrotizing
tracheitis and septal injury.
Chronic lung disease is defined as the need for
supplemental oxygen beyond 28days of postnatal







Arterial blood gas analyzers, flow sensors, oxygen
sensors, surfactant, total parenteral nutrition (TPN),
and disposable supplies (endotracheal tubes,
catheters, chest tubes, etc).
Reproduced with kind permission of the department
of Paediatrics and Child Health of the University of
Ilorin Teaching Hospital, Ilorin Nigeria owners of the
Ilorin Paediatric Digest 2010.
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